Maibach Romana C, Dutly Fabrizio, Altwegg Martin
Department of Medical Microbiology, University of Zurich, 8028 Zürich, Switzerland.
J Clin Microbiol. 2002 Jul;40(7):2466-71. doi: 10.1128/JCM.40.7.2466-2471.2002.
Whipple's disease is a rare multisystemic bacterial infection with variable clinical manifestations. For decades, the laboratory diagnosis was based on the demonstration of periodic acid Schiff-positive inclusions in macrophages of gastrointestinal biopsies. PCR has improved the diagnosis of Whipple's disease due to its increased sensitivity compared to histopathological analysis. To avoid invasive procedures for taking specimens, we have investigated the possibility of detecting Tropheryma whipplei DNA in feces rather than in biopsies or gastric aspirate of patients with and without Whipple's disease. Total bacterial DNA was isolated from stool specimens using Qiagen columns followed by a T. whipplei-specific hybridization step with a biotinylated capture probe and streptavidin-coated magnetic particles. The captured DNA was then amplified using the same seminested PCR targeting the 16S rRNA gene of the organism that had been applied to other specimens without capturing. For five of eight patients with Whipple's disease, duodenal biopsies and stool samples were PCR positive, whereas for the three other patients, both specimens were PCR negative. Of 84 patients without Whipple's disease, 75 tested negative in the duodenal biopsy and in the stool sample. For four, both specimens were positive. Five patients tested positive in the stool sample but not in the biopsy. However, for three of these five patients, the gastric aspirate had been PCR positive, indicating that the stool PCR result was true rather than false positive. Compared to PCR from duodenal biopsies, stool PCR has a sensitivity of 100% and a specificity of 97.3%. Additionally, 15 PCR-positive and 22 PCR-negative stool samples were extracted using the Invisorb Spin Stool DNA kit. The simplified stool extraction showed 93.3% sensitivity and 95.5% specificity compared to the target capture method. We conclude that PCR with stool specimens with either extraction method is a sensitive and specific diagnostic tool for the detection of T. whipplei DNA and one not requiring invasive sampling procedures.
惠普尔病是一种罕见的多系统细菌感染,临床表现多样。几十年来,实验室诊断一直基于在胃肠道活检的巨噬细胞中发现过碘酸希夫染色阳性包涵体。与组织病理学分析相比,聚合酶链反应(PCR)因其更高的灵敏度而改进了惠普尔病的诊断。为避免获取标本的侵入性操作,我们研究了在有或无惠普尔病的患者粪便中而非活检组织或胃抽吸物中检测惠普尔嗜组织菌DNA的可能性。使用Qiagen柱从粪便标本中分离总细菌DNA,随后用生物素化捕获探针和链霉亲和素包被的磁性颗粒进行惠普尔嗜组织菌特异性杂交步骤。然后使用与用于其他未捕获标本的相同半巢式PCR扩增捕获的DNA,该PCR靶向该生物体的16S rRNA基因。8例惠普尔病患者中有5例,十二指肠活检和粪便样本的PCR检测呈阳性,而另外3例患者的两种标本PCR检测均为阴性。在84例无惠普尔病的患者中,75例十二指肠活检和粪便样本检测为阴性。4例患者的两种标本均为阳性。5例患者粪便样本检测为阳性,但活检为阴性。然而,在这5例患者中的3例,胃抽吸物的PCR检测呈阳性,表明粪便PCR结果是真实的而非假阳性。与十二指肠活检的PCR相比,粪便PCR的灵敏度为100%,特异性为97.3%。此外,使用Invisorb Spin Stool DNA试剂盒提取了15份PCR阳性和22份PCR阴性的粪便样本。与目标捕获方法相比,简化的粪便提取显示灵敏度为93.3%,特异性为95.5%。我们得出结论,无论采用哪种提取方法,粪便标本的PCR都是检测惠普尔嗜组织菌DNA的灵敏且特异的诊断工具,且无需侵入性采样程序。